FDA-Approved Rapid AI-Enhanced Diagnosis

At RiseNow Autism Innovations, our diagnostic process begins with Canvas Dx by Cognoa, the first and only FDA-authorized (De Novo) artificial intelligence tool for evaluating developmental delay and autism spectrum disorder in children aged 18–72 months. This breakthrough technology dramatically shortens the traditional diagnostic timeline—often 12–24 months of waiting—delivering actionable results in days rather than months or years.

Canvas Dx combines three key data sources: parent-submitted home videos of natural behavior, caregiver questionnaires, and a brief clinician-guided interaction. The AI algorithm, trained on thousands of real-world cases across diverse ethnicities and socioeconomic backgrounds, achieves a specificity of 98% and positive predictive value of 80.8% when used as intended. These metrics rival or exceed many traditional assessments while dramatically improving equity of access.

Every Canvas Dx result is complemented by a comprehensive clinical evaluation performed by our board-certified psychiatric-mental health nurse practitioners. This dual-review process ensures diagnostic rigor: the AI identifies potential developmental concerns with remarkable consistency, while our clinicians integrate medical history, family observations, developmental milestones, and direct interaction to confirm or refine the findings. This “second opinion” approach virtually eliminates false positives and provides families with a diagnosis that is both technologically advanced and clinically validated.

The result is a definitive answer delivered in approximately four weeks from initial concern—often the fastest comprehensive evaluation available. Families leave with a clear diagnostic report, a personalized summary of strengths and needs, and immediate next steps, eliminating the prolonged uncertainty that can delay critical early intervention. This fusion of cutting-edge AI and expert clinical judgment represents the new standard in autism diagnosis: faster, more accurate, and more accessible than ever before.